As of 4:15pm ET
| -0.23 / -0.15%|
The 8 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 142.50, with a high estimate of 154.00 and a low estimate of 132.00. The median estimate represents a -4.01% decrease from the last price of 148.45.
The current consensus among 9 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.